Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study

• Main Authors: Marcello Moccia (Author), Giuseppina Affinito (Author), Giuseppina Marrazzo (Author), Tiziana Ciarambino (Author), Paolo Di Procolo (Author), Licia Confalonieri (Author), Antonio Carotenuto (Author), Maria Petracca (Author), Roberta Lanzillo (Author), Maria Triassi (Author), Vincenzo Brescia Morra (Author), Raffaele Palladino (Author)
• Format: Book
• Published: MDPI AG, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: We aim to provide up-to-date real-world evidence on the persistence, adherence, healthcare resource utilization, and costs of multiple sclerosis (MS) by comparing ocrelizumab to other disease-modifying treatments (DMTs) and within different DMT sequences. Methods: We included 3371 people...